This study reports a coordination-controlled colorimetric platform that translates lysine acetyltransferase 5 (KAT5) enzymatic activity into a visible plasmonic signal via controlled aggregation of gold nanoparticles (AuNPs). The detection principle is based on competition for Zn2+ coordination partners. Ethylenediamine (en) coordinates with Zn2+ to form Zn(en)22+ complexes; these complexes promote AuNP aggregation and produce a distinct localized surface plasmon resonance (LSPR) color change.
During the KAT5-catalyzed acetylation reaction, coenzyme A (CoA) is generated and carries a thiol group. Zn2+ preferentially binds the thiol-containing CoA rather than forming Zn(en)22+, thus suppressing Zn(en)22+ formation and preventing AuNP aggregation. Because AuNP aggregation state correlates with LSPR color, the presence and amount of CoA produced by KAT5 activity are indirectly reported as a preserved dispersed AuNP color (versus aggregated color). In short, higher KAT5 activity produces more CoA, sequesters Zn2+, inhibits Zn(en)22+-driven aggregation, and yields a measurable colorimetric signature.
The platform leverages simple coordination chemistry—Zn2+, en, and thiol interactions—combined with the strong optical response of AuNPs to produce a label-free, enzyme-activity-dependent color readout.
To enable portable, point-of-care-capable readout, the authors integrated smartphone imaging and processing. Photographs of assay wells or samples are analyzed using the blue-to-red (B/R) ratio extracted from images. The B/R ratio provides a quantitative measure of the AuNPs' plasmonic color state and therefore of KAT5 activity through the described coordination mechanism.
Smartphone-based analysis supports on-site measurements without specialized spectrophotometers, facilitating potential translation into resource-limited or decentralized settings. The abstract reports use of the B/R ratio as the quantification metric; further technical details of the imaging setup, software, calibration, and image-processing workflow are provided in the full text (not included in the abstract).
The authors reported a detection limit for KAT5 activity of 1.9 pg/mL, calculated as 3σ/slope. This value reflects the assay's reported analytical sensitivity under the experimental conditions described in the publication abstract. The assay converts enzymatic activity into an optical change measurable by either spectrophotometry or smartphone imaging via the B/R metric.
The abstract does not include additional analytical parameters such as linear range, intra- and inter-assay precision, matrix effects, or specificity against other acetyltransferases; those details would require direct consultation of the full article for experimental protocols and validation data.
The assay was applied to investigate histone acetylation in cancer cells, using KAT5 activity as a surrogate for epigenetic modification status. By detecting CoA produced during histone acetylation, the platform enabled monitoring of KAT5 enzymatic activity dynamics in cell-based experiments. The abstract indicates successful measurement of histone acetylation-associated KAT5 activity changes, demonstrating the method's utility for cell-level biochemical investigations related to cancer biology.
Specific experimental conditions, cell lines, sample preparation, or comparative controls used in these experiments are not detailed in the abstract and would be found in the full paper.
The authors extended the platform to circulating tumor cell (CTC)-like models undergoing epithelial–mesenchymal transition (EMT). Using these models, they observed dynamic changes in KAT5 activity during EMT, suggesting the assay can report on enzyme activity shifts associated with phenotypic transitions relevant to metastasis and tumor dissemination.
The abstract frames this application as proof-of-concept for monitoring enzymatic markers in CTC-relevant contexts, which could inform studies of tumor progression and metastatic biology. Details such as the preparation of CTC-like models, sample volumes, enrichment methods, or clinical sample testing were not reported in the abstract.
The authors propose that this coordination-mediated AuNPs strategy provides a simple and portable tool for monitoring cancer-related enzymatic activity with potential uses in liquid biopsy, early cancer diagnosis, and precision medicine. The assay's advantages highlighted in the abstract include the visual, LSPR-based readout, smartphone-enabled quantification, and sensitivity down to 1.9 pg/mL.
Limitations and open questions based on the abstract:
In summary, the published abstract describes a coordination-chemistry-driven AuNP aggregation assay that correlates KAT5 activity to a plasmonic color change, quantified by smartphone-derived B/R ratios, with a reported detection limit of 1.9 pg/mL and demonstrated applicability to cancer-cell and CTC-like model systems. For replication, clinical validation, and implementation details, the full article should be consulted.